Subscribe
shutterstock_492675739_mdart10
MDart10 / Shutterstock.com
10 May 2022BiotechnologyAlex Baldwin

L’Oreal’s anti-wrinkle cosmetics infringe, claims GlycoBioSciences

Canadian pharmaceutical company  GlycoBioSciences has sued cosmetics giant  L’Oreal, alleging that the French company’s anti-wrinkle products containing hyaluronic acid infringe two patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.
Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.


Editor's picks

Trouble at the USPTO—Part II: Bracing for impact
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025

Editor's picks

Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025
Americas
LSPN finalists revealed for first-ever US awards
3 March 2025
Europe
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
27 February 2025

More on this story

article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.
Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.

More on this story

article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.
Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.

More features

‘Always new twists’: Bayer legal team on defending a $4bn drug
Novartis and MSN feud intensifies after Fed Circ denies rehearing
EU court signals tough stance on ‘pay-for-delay’ pharma deals
Panitch Schwarze hires experienced ex-USPTO examiner
Fed Circ affirms generic’s litigation costs of $12m are tax-deductible
Genmab fights claim over 'secrets theft' behind $1.8bn takeover
European court upholds 10x patent after Nanostring appealed injunction
Takeda, Pfizer, and Sumitomo sue to protect $379m Orgovyx revenue